Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportOncology, Basic Science Track

Chinese data of efficacy of low- and high-dose of iodine-131 for the ablation of thyroid remnant

Fang Feng, Chao Ma and Hui Wang
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1451;
Fang Feng
1Department of Nuclear Medicine, Xinhua Hospital Shanghai China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chao Ma
1Department of Nuclear Medicine, Xinhua Hospital Shanghai China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hui Wang
1Department of Nuclear Medicine, Xinhua Hospital Shanghai China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Figures & Data

Tables

  • 1850 MBq n=1553700 MBq n=123t/χ2P
    Age-yr44±1345±13-0.7160.475
    Female sex-no. (%)112 (72.3%)87 (70.7%)0.0790.790
    Time from thyroidectomy to thyroid ablation-days53±3055±36-0.5650.572
    Type of thyroidectomy-no. (%)
    Total thyroidectomy145 (93.5%)109 (88.6%)
    Near total thyroidectomy10 (6.5%)14 (11.4%)2.1140.197
    Histology-no. (%)
    Papillary151 (97.4%)117 (95.1%)
    Follicular3 (1.9%)4 (3.3%)
    Mix1 (0.6%)2 (1.6%)1.121.591
    Tumor size (cm)1.46±1.521.39±0.980.4220.673
    Multifocal cancer-no. (%)
    Yes87 (56.1%)62 (50.4%)
    No64 (41.3%)57 (46.3%)
    Unknown4 (2.6%)4 (3.3%)0.9280.629
    T Stage-no. (%)
    T194 (60.6%)77 (62.6%)
    T219 (12.3%)12 (9.8%)
    T328 (18.1%)21 (17.1%)
    Tx (Unknown size)14 (9.0%)13 (10.6%)3.1430.556
    Lymph node metastasis-no. (%)
    N048 (30.9%)36 (29.3%)
    N1a66 (42.6%)54 (43.9%)
    N1b41(26.5%)33 (26.8%)0.8510.993
    Serum Tg (ng/ml)10.04±19.8012.84±24.82-1.0460.296
    TSH (uIU/ml)70.67±34.9565.80±32.761.1860.237
    131I-WBS-no. (%)
    Stage I5 (3.2%)5 (4.1%)
    Stage II41 (26.5%)22 (17.9%)
    Stage III109 (70.3%)96 (78.0%)2.9100.244
    Positive Anti-Tg Ab-no. (%)34 (22.1%)36 (29.3%)1.8720.210
    Residence place-no. (%)
    Coastal areas136 (87.7%)110 (89.4%)
    Non-coastal areas19 (12.3%)13 (10.6%)0.1920.709
  • Odds of success vs unsuccessful ablation for the first value proportionate to the second value
    Independent predicting factorsP valuesOR95% CI for OR
    Predictors of first-dose successful ablation
    Age0.0221.0401.006-1.075
    TgAb-off0.0202.6511.164-6.040
    The factors not associated with treatment response
    Dose of administered 131I: 1850 vs. 3700 (MBq)0.4650.7240.304-1.723
    Sex: female vs. male0.2911.8120.300-5.471
    Residence:0.8380.8740.240-3.183
    Interval0.6840.6360.072-5.601
    Size0.4091.2320.751-2.021
    LNM: Yes or not0.1000.3530.103-1.218
    Baseline serum Tg0.2520.9830.955-1.012
    Baseline serum TSH0.9011.0010.988-1.014
    Type of thyroidectomy: TT vs. NTT0.72607570.160-3.579
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Chinese data of efficacy of low- and high-dose of iodine-131 for the ablation of thyroid remnant
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Chinese data of efficacy of low- and high-dose of iodine-131 for the ablation of thyroid remnant
Fang Feng, Chao Ma, Hui Wang
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1451;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Chinese data of efficacy of low- and high-dose of iodine-131 for the ablation of thyroid remnant
Fang Feng, Chao Ma, Hui Wang
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1451;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Basic Science Track

  • Imaging adult glioma with 68Ga-citrate PET/MR
  • Evaluation of L-1-[18F]Fluoroethyl-Tryptophan for PET Imaging of Cancer
  • Pretargeted radioimmunotherapy with 225Ac-proteus-DOTA hapten.
Show more Oncology, Basic Science Track

MTA I: Radiopharmaceutical Therapy Posters

  • Therapeutic Effect of I-131-labeled Chitosan Hydrogels on Treatment of Hepatic Cancer: Focused on In vivo Rodent Orthotopic Hepatic Cancer Models
  • Predictors of better response to radioligand therapy of metastatic castrate-resistant prostate cancer with 177Lu-PSMA-617
  • Difference in thyroid uptake between Astatine-211 and Iodine-123 in normal rats: a comparative study between oral and intravenous administration.
Show more MTA I: Radiopharmaceutical Therapy Posters

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire